CA2259967A1 - Peptide reagent for the detection of human cytomegalovirus (cmv) - Google Patents

Peptide reagent for the detection of human cytomegalovirus (cmv)

Info

Publication number
CA2259967A1
CA2259967A1 CA002259967A CA2259967A CA2259967A1 CA 2259967 A1 CA2259967 A1 CA 2259967A1 CA 002259967 A CA002259967 A CA 002259967A CA 2259967 A CA2259967 A CA 2259967A CA 2259967 A1 CA2259967 A1 CA 2259967A1
Authority
CA
Canada
Prior art keywords
cmv
detection
antibodies
human cytomegalovirus
peptide reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002259967A
Other languages
French (fr)
Other versions
CA2259967C (en
Inventor
Jaap Michiel Middeldorp
Johannes Martinus Gerardus Van De Crommert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/EP1997/003717 external-priority patent/WO1998002746A1/en
Publication of CA2259967A1 publication Critical patent/CA2259967A1/en
Application granted granted Critical
Publication of CA2259967C publication Critical patent/CA2259967C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

The invention relates to a peptide reagent comprising peptides immunochemically reactive with antibodies to the human cytomegalovirus (CMV). New antibodies directed to said peptides or fragments thereof are also part of the invention. Also cell lines capable of producing monoclonal antibodies are part of the invention. The invention also relates to a method for the detection of CMV
or antibodies directed against CMV in a test fluid and a test kit to be used when applying the said detection methods. Detection of CMV
in a test fluid or tissue specimen using antibodies, monoclonal and polyclonal, directed to said peptide, which have the characteristics of detecting both native and denatured CMV proteins are also part of said invention.
CA002259967A 1996-07-12 1997-07-09 Peptide reagent for the detection of human cytomegalovirus (cmv) Expired - Lifetime CA2259967C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96201972 1996-07-12
EP96201972.5 1996-07-12
PCT/EP1997/003717 WO1998002746A1 (en) 1996-07-12 1997-07-09 Peptide reagent for the detection of human cytomegalovirus (cmv)

Publications (2)

Publication Number Publication Date
CA2259967A1 true CA2259967A1 (en) 1998-01-22
CA2259967C CA2259967C (en) 2006-04-11

Family

ID=36178213

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002259967A Expired - Lifetime CA2259967C (en) 1996-07-12 1997-07-09 Peptide reagent for the detection of human cytomegalovirus (cmv)

Country Status (1)

Country Link
CA (1) CA2259967C (en)

Also Published As

Publication number Publication date
CA2259967C (en) 2006-04-11

Similar Documents

Publication Publication Date Title
EP1104887A3 (en) A method and test kit for assaying collagen fragments in body fluids
AU3623197A (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
WO2001087919A3 (en) Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins
SE9500023D0 (en) Method of detecting cancer
WO1995014778A3 (en) Dna sequence coding for a bmp receptor
AU2002223044A1 (en) Kit and method for detecting the esm-1 protein
CA2234416A1 (en) Immunochemical determination of multivalent analytes
AU5479396A (en) Epstein-Barr virus peptides and antibodies against these peptides
EP1652918A3 (en) Methods for detecting protein interactions using conformationally constrained peptides
WO2001044809A3 (en) Evaluation of biological agents in living target cells
WO2000007024A3 (en) Method of protein analysis
CA2120342A1 (en) Epstein-barr virus peptides and antibodies against these peptides
EP0387027A3 (en) Endometriosis diagnosis methods and reagents
CA2259967A1 (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
AU5692699A (en) Apparatus for rapid protein and polypeptide sequence analysis
AU6443494A (en) An endogenous taxol-like substance in human serum, monoclonal antibodies directed thereto, and methods of assaying therefor
AU4381897A (en) New Brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
CA2140091A1 (en) Peptides and antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2
ATE228249T1 (en) IMMUNE TEST FOR DETECTION OF HUMAN CYTOMEGALOVIRUS SPECIFIC IGM
EP0985931A3 (en) Recombinant antigen immunoassay for the diagnosis of syphilis
WO1997039143A3 (en) Methods for the identification of novel antifungal agents
WO1993011158A3 (en) Non-a, non-b peptides
EP1712629A3 (en) Compounds and methods for diagnosis of tuberculosis
CA2250047A1 (en) Monoclonal antibodies binding human growth hormone (hgh)
AU6642698A (en) Immunoassay and kit for iga antibodies specific for acetaldehyde adducts

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170710